{
    "hands_on_practices": [
        {
            "introduction": "The onset of copious milk secretion, known as lactogenesis II, is critically timed by the rapid postpartum withdrawal of progesterone. Clinical issues like retained placental fragments can disrupt this hormonal signal, leading to significant delays. This practice problem  allows you to quantitatively model this delay, applying principles of receptor kinetics and hormone clearance to translate a physiological disruption into a predictable clinical outcome.",
            "id": "4462090",
            "problem": "A fundamental endocrine determinant of the onset of secretory activation (lactogenesis II) in the postpartum period is the withdrawal of progesterone-mediated inhibition of prolactin-driven Signal Transducer and Activator of Transcription 5 (STAT5) signaling in mammary alveolar epithelial cells. Assume that progesterone ($P$) inhibits the pathway via receptor occupancy that follows the law of mass action binding for a single non-cooperative receptor class: the fractional occupancy is $f(P) = \\frac{P}{P + K_{d}}$, where $K_{d}$ is the dissociation constant. Suppose secretory activation begins once the inhibitory occupancy falls below a critical fraction $f_{c}$; that is, when $f(P) < f_{c}$.\n\nPostpartum serum progesterone decays by first-order clearance, so that in the absence of any continued production after placental delivery at time $t=0$, the concentration is $P(t) = P_{0}\\exp(-k t)$, where $P_{0}$ is the concentration at $t=0$ and $k$ is the first-order rate constant related to the half-life $t_{1/2}$ by $k = \\frac{\\ln 2}{t_{1/2}}$. In a complication with retained placental fragments, trophoblastic tissue sustains maternal serum progesterone at an approximately constant level $P_{s}$ so long as the fragments remain, and they are removed at time $t = t_{r}$, after which the concentration decays from $P_{s}$ with the same first-order clearance.\n\nAssume the following physiologically plausible parameters:\n- $K_{d} = 2.0\\,\\mathrm{nM}$, $f_{c} = 0.10$,\n- $P_{0} = 450\\,\\mathrm{nM}$,\n- $t_{1/2} = 0.25\\,\\mathrm{h}$,\n- $P_{s} = 5.0\\,\\mathrm{nM}$,\n- $t_{r} = 36\\,\\mathrm{h}$.\n\nFor both the uncomplicated and the retained-fragment scenarios, assume there is a fixed downstream integration time $T_{i}$ between crossing the inhibitory threshold and the observable onset of lactogenesis II, and that $T_{i}$ is the same in both scenarios. Under these assumptions, compute the expected delay in the onset time attributable solely to sustained progesterone from the retained fragments (i.e., the difference between the onset times in the retained-fragment versus uncomplicated scenarios). Express your final answer in hours, and round to three significant figures. Do not include units in your final boxed answer.",
            "solution": "The problem asks for the delay in the onset of lactogenesis II caused by retained placental fragments sustaining maternal progesterone levels. This delay is the difference in the time of secretory activation between the complicated (retained fragments) and uncomplicated scenarios.\n\nFirst, we must determine the critical progesterone concentration, $P_c$, at which secretory activation is permitted to begin. The problem states that activation occurs when the fractional occupancy of the progesterone receptor, $f(P)$, falls below a critical fraction, $f_c$. The threshold is crossed at the time $t_{cross}$ when $f(P(t_{cross})) = f_c$.\n\nThe fractional occupancy is given by the mass-action binding model:\n$$f(P) = \\frac{P}{P + K_{d}}$$\nSetting $f(P_c) = f_c$, we can solve for the critical concentration $P_c$:\n$$\\frac{P_c}{P_c + K_{d}} = f_c$$\n$$P_c = f_c (P_c + K_{d})$$\n$$P_c - f_c P_c = f_c K_d$$\n$$P_c(1 - f_c) = f_c K_d$$\n$$P_c = \\frac{f_c K_d}{1 - f_c}$$\nUsing the provided parameters $K_d = 2.0\\,\\mathrm{nM}$ and $f_c = 0.10$:\n$$P_c = \\frac{0.10 \\times 2.0\\,\\mathrm{nM}}{1 - 0.10} = \\frac{0.20}{0.90}\\,\\mathrm{nM} = \\frac{2}{9}\\,\\mathrm{nM}$$\n\nNext, we establish the progesterone concentration decay kinetics. The decay is a first-order process with rate constant $k$, related to the half-life $t_{1/2}$ by:\n$$k = \\frac{\\ln 2}{t_{1/2}}$$\nGiven $t_{1/2} = 0.25\\,\\mathrm{h}$:\n$$k = \\frac{\\ln 2}{0.25\\,\\mathrm{h}} = 4 \\ln 2 \\,\\,\\mathrm{h}^{-1}$$\n\nNow, we calculate the time to reach the threshold $P_c$ for each scenario. Let $t_{cross, uncomp}$ be the crossing time for the uncomplicated scenario and $t_{cross, retained}$ for the retained-fragment scenario. The observable onset of lactation occurs at a fixed time $T_i$ after these crossing times, so $t_{onset} = t_{cross} + T_i$.\n\nIn the uncomplicated scenario, the progesterone concentration $P(t)$ starts at $P_0$ at $t=0$ and decays as:\n$$P(t) = P_0 \\exp(-kt)$$\nThe threshold is crossed when $P(t_{cross, uncomp}) = P_c$:\n$$P_0 \\exp(-k t_{cross, uncomp}) = P_c$$\n$$\\exp(-k t_{cross, uncomp}) = \\frac{P_c}{P_0}$$\n$$-k t_{cross, uncomp} = \\ln\\left(\\frac{P_c}{P_0}\\right)$$\n$$t_{cross, uncomp} = -\\frac{1}{k} \\ln\\left(\\frac{P_c}{P_0}\\right) = \\frac{1}{k} \\ln\\left(\\frac{P_0}{P_c}\\right)$$\n\nIn the retained-fragment scenario, the progesterone concentration is held constant at $P_s = 5.0\\,\\mathrm{nM}$ until time $t_r = 36\\,\\mathrm{h}$. Since $P_s = 5.0\\,\\mathrm{nM}$ is greater than $P_c = \\frac{2}{9}\\,\\mathrm{nM} \\approx 0.222\\,\\mathrm{nM}$, the threshold is not crossed during the interval $[0, t_r]$. For $t > t_r$, the concentration decays from $P_s$ starting at time $t_r$:\n$$P(t) = P_s \\exp(-k(t - t_r))$$\nThe threshold is crossed when $P(t_{cross, retained}) = P_c$:\n$$P_s \\exp(-k(t_{cross, retained} - t_r)) = P_c$$\n$$\\exp(-k(t_{cross, retained} - t_r)) = \\frac{P_c}{P_s}$$\n$$-k(t_{cross, retained} - t_r) = \\ln\\left(\\frac{P_c}{P_s}\\right)$$\n$$t_{cross, retained} - t_r = \\frac{1}{k} \\ln\\left(\\frac{P_s}{P_c}\\right)$$\n$$t_{cross, retained} = t_r + \\frac{1}{k} \\ln\\left(\\frac{P_s}{P_c}\\right)$$\n\nThe delay in the onset of lactogenesis II, $\\Delta t_{onset}$, is the difference between the onset times of the two scenarios. Since the downstream integration time $T_i$ is the same for both, it cancels out:\n$$\\Delta t_{onset} = t_{onset, retained} - t_{onset, uncomp}$$\n$$\\Delta t_{onset} = (t_{cross, retained} + T_i) - (t_{cross, uncomp} + T_i)$$\n$$\\Delta t_{onset} = t_{cross, retained} - t_{cross, uncomp}$$\nSubstituting the expressions for the crossing times:\n$$\\Delta t_{onset} = \\left(t_r + \\frac{1}{k} \\ln\\left(\\frac{P_s}{P_c}\\right)\\right) - \\left(\\frac{1}{k} \\ln\\left(\\frac{P_0}{P_c}\\right)\\right)$$\nUsing the property of logarithms $\\ln(a) - \\ln(b) = \\ln(a/b)$:\n$$\\Delta t_{onset} = t_r + \\frac{1}{k} \\left( \\ln\\left(\\frac{P_s}{P_c}\\right) - \\ln\\left(\\frac{P_0}{P_c}\\right) \\right)$$\n$$\\Delta t_{onset} = t_r + \\frac{1}{k} \\ln\\left(\\frac{P_s/P_c}{P_0/P_c}\\right)$$\n$$\\Delta t_{onset} = t_r + \\frac{1}{k} \\ln\\left(\\frac{P_s}{P_0}\\right)$$\n\nFinally, we substitute the numerical values into this expression:\n$t_r = 36\\,\\mathrm{h}$\n$k = 4 \\ln 2 \\,\\,\\mathrm{h}^{-1}$\n$P_s = 5.0\\,\\mathrm{nM}$\n$P_0 = 450\\,\\mathrm{nM}$\n\n$$\\Delta t_{onset} = 36\\,\\mathrm{h} + \\frac{1}{4 \\ln 2 \\,\\,\\mathrm{h}^{-1}} \\ln\\left(\\frac{5.0\\,\\mathrm{nM}}{450\\,\\mathrm{nM}}\\right)$$\n$$\\Delta t_{onset} = 36 + \\frac{1}{4 \\ln 2} \\ln\\left(\\frac{1}{90}\\right)$$\nSince $\\ln(1/x) = -\\ln(x)$:\n$$\\Delta t_{onset} = 36 - \\frac{\\ln(90)}{4 \\ln 2}$$\nNow, we calculate the numerical value:\n$\\ln(90) \\approx 4.49980967$\n$\\ln(2) \\approx 0.69314718$\n$$4 \\ln 2 \\approx 2.77258872$$\n$$\\Delta t_{onset} \\approx 36 - \\frac{4.49980967}{2.77258872} \\approx 36 - 1.6231410$$\n$$\\Delta t_{onset} \\approx 34.376859\\,\\mathrm{h}$$\nRounding to three significant figures, the delay is $34.4\\,\\mathrm{h}$.",
            "answer": "$$\\boxed{34.4}$$"
        },
        {
            "introduction": "The transfer of medications into breast milk is not a simple passive process; it is profoundly influenced by the physicochemical properties of both the drug and the biological compartments. Human milk is slightly more acidic than plasma, a fact that can lead to the \"ion trapping\" of certain drugs, causing them to accumulate in milk at concentrations higher than in the mother's blood. This exercise  will guide you through the derivation of the milk-to-plasma ($R_{m/p}$) ratio using the Henderson-Hasselbalch equation, providing a fundamental understanding of why and how weak bases can become concentrated in breast milk.",
            "id": "4462122",
            "problem": "A monoprotic weak base, denoted by $B$ (unionized) and $BH^{+}$ (ionized), distributes between maternal plasma and human milk. The acid dissociation constant of the conjugate acid is $\\mathrm{p}K_{a} = 8.5$. The maternal plasma has $\\mathrm{pH} = 7.4$, and human milk has $\\mathrm{pH} = 7.0$. Assume the following:\n- Only the unionized form $B$ crosses the mammary epithelium by passive diffusion on the relevant time scale.\n- There is negligible protein binding in either compartment, no active transport, and no electrical potential difference across the barrier.\n- At passive equilibrium, the concentration of $B$ is equal in plasma and milk.\n\nStarting from the Henderson–Hasselbalch relationship for a weak base and fundamental mass action principles, do the following:\n1) Derive the fraction of drug present as unionized $B$ and as ionized $BH^{+}$ as functions of $\\mathrm{pH}$ and $\\mathrm{p}K_{a}$, and compute these fractions in plasma ($\\mathrm{pH} = 7.4$) and milk ($\\mathrm{pH} = 7.0$) for $\\mathrm{p}K_{a} = 8.5$.\n2) Using the assumption that only $B$ equilibrates across the barrier and that its concentration is equal in both compartments at equilibrium, derive an expression for the milk-to-plasma total concentration ratio $R_{m/p}$ in terms of $\\mathrm{pH}$ and $\\mathrm{p}K_{a}$ for a monoprotic weak base.\n3) Evaluate $R_{m/p}$ numerically for $\\mathrm{pH}_{\\text{plasma}} = 7.4$, $\\mathrm{pH}_{\\text{milk}} = 7.0$, and $\\mathrm{p}K_{a} = 8.5$.\n\nProvide your final answer as the single dimensionless number $R_{m/p}$, rounded to four significant figures.",
            "solution": "A monoprotic weak base, $B$, and its conjugate acid, $BH^{+}$, exist in equilibrium in an aqueous solution. The equilibrium is governed by the dissociation of the conjugate acid:\n$$\nBH^{+} \\rightleftharpoons B + H^{+}\n$$\nThe acid dissociation constant, $K_a$, for this equilibrium is defined as:\n$$\nK_a = \\frac{[B][H^{+}]}{[BH^{+}]}\n$$\nwhere brackets denote molar concentrations. By taking the negative base-$10$ logarithm of this equation, we can express it in terms of $\\mathrm{p}K_a$ and $\\mathrm{pH}$:\n$$\n-\\log_{10}(K_a) = -\\log_{10}\\left(\\frac{[B][H^{+}]}{[BH^{+}]}\\right)\n$$\n$$\n\\mathrm{p}K_a = -\\log_{10}([H^{+}]) - \\log_{10}\\left(\\frac{[B]}{[BH^{+}]}\\right)\n$$\nThis yields the Henderson-Hasselbalch equation:\n$$\n\\mathrm{p}K_a = \\mathrm{pH} - \\log_{10}\\left(\\frac{[B]}{[BH^{+}]}\\right)\n$$\nThis equation is the foundation for our derivations.\n\n1) Derivation and computation of the fractions of unionized and ionized drug.\n\nThe total concentration of the drug, $C_{total}$, is the sum of the concentrations of the unionized form ($B$) and the ionized form ($BH^{+}$):\n$$\nC_{total} = [B] + [BH^{+}]\n$$\nThe fraction of the drug in the unionized form, $f_u$, is given by:\n$$\nf_u = \\frac{[B]}{C_{total}} = \\frac{[B]}{[B] + [BH^{+}]}\n$$\nThe fraction of the drug in the ionized form, $f_i$, is given by:\n$$\nf_i = \\frac{[BH^{+}]}{C_{total}} = \\frac{[BH^{+}]}{[B] + [BH^{+}]}\n$$\nNote that $f_u + f_i = 1$.\n\nTo express these fractions in terms of $\\mathrm{pH}$ and $\\mathrm{p}K_a$, we first rearrange the Henderson-Hasselbalch equation to find the ratio of $[B]$ to $[BH^{+}]$:\n$$\n\\log_{10}\\left(\\frac{[B]}{[BH^{+}]}\\right) = \\mathrm{pH} - \\mathrm{p}K_a\n$$\n$$\n\\frac{[B]}{[BH^{+}]} = 10^{\\mathrm{pH} - \\mathrm{p}K_a}\n$$\nNow, we can substitute this relationship into the definitions of $f_u$ and $f_i$. For $f_u$, we divide the numerator and denominator by $[BH^{+}]$:\n$$\nf_u = \\frac{[B]/[BH^{+}]}{[B]/[BH^{+}] + 1} = \\frac{10^{\\mathrm{pH} - \\mathrm{p}K_a}}{10^{\\mathrm{pH} - \\mathrm{p}K_a} + 1}\n$$\nFor $f_i$, we divide the numerator and denominator by $[BH^{+}]$:\n$$\nf_i = \\frac{1}{[B]/[BH^{+}] + 1} = \\frac{1}{10^{\\mathrm{pH} - \\mathrm{p}K_a} + 1}\n$$\nNow, we compute these fractions for plasma and milk using the given values: $\\mathrm{p}K_a = 8.5$, $\\mathrm{pH}_{\\text{plasma}} = 7.4$, and $\\mathrm{pH}_{\\text{milk}} = 7.0$.\n\nIn maternal plasma ($\\mathrm{pH} = 7.4$):\nThe exponent is $\\mathrm{pH}_{\\text{plasma}} - \\mathrm{p}K_a = 7.4 - 8.5 = -1.1$.\n$$\nf_{u, \\text{plasma}} = \\frac{10^{-1.1}}{10^{-1.1} + 1} \\approx \\frac{0.07943}{1.07943} \\approx 0.07359\n$$\n$$\nf_{i, \\text{plasma}} = \\frac{1}{10^{-1.1} + 1} \\approx \\frac{1}{1.07943} \\approx 0.92641\n$$\nSo, in plasma, approximately $7.4\\%$ of the drug is unionized and $92.6\\%$ is ionized.\n\nIn human milk ($\\mathrm{pH} = 7.0$):\nThe exponent is $\\mathrm{pH}_{\\text{milk}} - \\mathrm{p}K_a = 7.0 - 8.5 = -1.5$.\n$$\nf_{u, \\text{milk}} = \\frac{10^{-1.5}}{10^{-1.5} + 1} \\approx \\frac{0.03162}{1.03162} \\approx 0.03065\n$$\n$$\nf_{i, \\text{milk}} = \\frac{1}{10^{-1.5} + 1} \\approx \\frac{1}{1.03162} \\approx 0.96935\n$$\nSo, in milk, approximately $3.1\\%$ of the drug is unionized and $96.9\\%$ is ionized.\n\n2) Derivation of the milk-to-plasma total concentration ratio, $R_{m/p}$.\n\nThe total concentration in plasma, $C_p$, and milk, $C_m$, are:\n$$\nC_p = [B]_p + [BH^{+}]_p\n$$\n$$\nC_m = [B]_m + [BH^{+}]_m\n$$\nThe central assumption is that at passive equilibrium, the concentration of the unionized, membrane-permeable form $B$ is equal in both compartments:\n$$\n[B]_p = [B]_m\n$$\nFrom the Henderson-Hasselbalch equation, we can express $[BH^{+}]$ in terms of $[B]$:\n$$\n[BH^{+}] = \\frac{[B]}{10^{\\mathrm{pH} - \\mathrm{p}K_a}} = [B] \\cdot 10^{\\mathrm{p}K_a - \\mathrm{pH}}\n$$\nWe can write the total concentrations in each compartment as:\n$$\nC_p = [B]_p + [B]_p \\cdot 10^{\\mathrm{p}K_a - \\mathrm{pH}_p} = [B]_p \\left(1 + 10^{\\mathrm{p}K_a - \\mathrm{pH}_p}\\right)\n$$\n$$\nC_m = [B]_m + [B]_m \\cdot 10^{\\mathrm{p}K_a - \\mathrm{pH}_m} = [B]_m \\left(1 + 10^{\\mathrm{p}K_a - \\mathrm{pH}_m}\\right)\n$$\nThe milk-to-plasma ratio, $R_{m/p}$, is the ratio of the total concentrations:\n$$\nR_{m/p} = \\frac{C_m}{C_p} = \\frac{[B]_m \\left(1 + 10^{\\mathrm{p}K_a - \\mathrm{pH}_m}\\right)}{[B]_p \\left(1 + 10^{\\mathrm{p}K_a - \\mathrm{pH}_p}\\right)}\n$$\nSince $[B]_m = [B]_p$, these terms cancel, yielding the final expression for the ratio:\n$$\nR_{m/p} = \\frac{1 + 10^{\\mathrm{p}K_a - \\mathrm{pH}_m}}{1 + 10^{\\mathrm{p}K_a - \\mathrm{pH}_p}}\n$$\nThis expression shows that the distribution ratio for a weak base depends on its $\\mathrm{p}K_a$ and the $\\mathrm{pH}$ gradient across the membrane.\n\n3) Evaluation of $R_{m/p}$ numerically.\n\nWe substitute the given values into the derived expression: $\\mathrm{p}K_a = 8.5$, $\\mathrm{pH}_m = 7.0$, and $\\mathrm{pH}_p = 7.4$.\n$$\nR_{m/p} = \\frac{1 + 10^{8.5 - 7.0}}{1 + 10^{8.5 - 7.4}} = \\frac{1 + 10^{1.5}}{1 + 10^{1.1}}\n$$\nNow, we calculate the numerical value:\n$$\n10^{1.5} \\approx 31.6227766\n$$\n$$\n10^{1.1} \\approx 12.5892541\n$$\n$$\nR_{m/p} = \\frac{1 + 31.6227766}{1 + 12.5892541} = \\frac{32.6227766}{13.5892541} \\approx 2.4006203\n$$\nRounding the result to four significant figures, we get $2.401$. This phenomenon, where the total concentration of a weak base is higher in the more acidic compartment (milk) than in the less acidic compartment (plasma), is known as \"ion trapping\".",
            "answer": "$$\\boxed{2.401}$$"
        },
        {
            "introduction": "Building upon the principles of drug distribution, a clinician's ultimate responsibility is to assess the potential risk to the breastfed infant. This requires synthesizing information about maternal dosing, the drug's pharmacokinetic properties, and the principles of its transfer into milk. This hands-on practice  integrates these elements into a single, clinically relevant calculation to estimate the infant's daily drug dose and compare it to a known safety threshold. By mastering this quantitative risk assessment, you will be better equipped to make evidence-based recommendations regarding medication use during lactation.",
            "id": "4462073",
            "problem": "A lactating patient is prescribed an oral medication with linear pharmacokinetics (PK), reaching steady state under chronic dosing. Assume first-order elimination and that average input to the systemic circulation equals average elimination at steady state. The following parameters are known:\n\n- Oral bioavailability $F = 0.70$.\n- Maternal dosing regimen: single dose per interval $D = 300$ mg every $\\tau = 12$ h.\n- Maternal systemic clearance $CL = 15$ L/h.\n- Milk-to-plasma (M:P) concentration ratio $R = 0.90$ (dimensionless).\n- Exclusively breastfed infant’s daily milk intake, normalized by body mass: $V_{\\text{milk}} = 0.15$ L$\\cdot$kg$^{-1}\\cdot$day$^{-1}$.\n- Pediatric minimum therapeutic threshold for this drug: $T_{\\text{ped}} = 5$ mg$\\cdot$kg$^{-1}\\cdot$day$^{-1}$.\n\nUsing a mass-balance framework at steady state and the above definitions, derive the maternal average steady-state plasma concentration, map it to average milk concentration via $R$, then compute the infant’s daily dose in mg$\\cdot$kg$^{-1}\\cdot$day$^{-1}$ from the milk concentration and intake volume per kilogram. Finally, quantify safety by computing the hazard quotient $HQ$, defined as the ratio of the infant’s daily dose (mg$\\cdot$kg$^{-1}\\cdot$day$^{-1}$) to $T_{\\text{ped}}$ (mg$\\cdot$kg$^{-1}\\cdot$day$^{-1}$). \n\nReport the final answer as the unitless hazard quotient $HQ$. Round your final answer to three significant figures.",
            "solution": "The solution proceeds by following the steps outlined in the problem statement. All calculations are first derived symbolically and then computed numerically.\n\nFirst, we determine the maternal average steady-state plasma concentration, $C_{p,ss,avg}$. At steady state, the average rate of drug administration into the systemic circulation is equal to the average rate of elimination.\n\nThe average rate of drug input is given by the bioavailable fraction of the dose divided by the dosing interval:\n$$ \\text{Rate}_{\\text{in}} = \\frac{F \\cdot D}{\\tau} $$\nThe average rate of drug elimination is the product of the systemic clearance and the average steady-state plasma concentration:\n$$ \\text{Rate}_{\\text{out}} = CL \\cdot C_{p,ss,avg} $$\nEquating these rates, $\\text{Rate}_{\\text{in}} = \\text{Rate}_{\\text{out}}$, yields:\n$$ \\frac{F \\cdot D}{\\tau} = CL \\cdot C_{p,ss,avg} $$\nSolving for $C_{p,ss,avg}$:\n$$ C_{p,ss,avg} = \\frac{F \\cdot D}{CL \\cdot \\tau} $$\n\nNext, we calculate the average drug concentration in the breast milk, $C_{milk,avg}$. This is determined using the given milk-to-plasma (M:P) ratio, $R$:\n$$ C_{milk,avg} = R \\cdot C_{p,ss,avg} $$\nSubstituting the expression for $C_{p,ss,avg}$:\n$$ C_{milk,avg} = R \\cdot \\left( \\frac{F \\cdot D}{CL \\cdot \\tau} \\right) $$\n\nNow, we compute the infant's daily dose, normalized by body mass, which we denote as $Dose_{infant}$. This is the product of the average milk concentration and the infant's normalized daily milk intake, $V_{\\text{milk}}$. It is critical to ensure unit consistency. The term $C_{milk,avg}$ will be in units of mg/L. The given $V_{\\text{milk}}$ is in L$\\cdot$kg$^{-1}\\cdot$day$^{-1}$. The product will correctly yield a dose in mg$\\cdot$kg$^{-1}\\cdot$day$^{-1}$.\n$$ Dose_{infant} = C_{milk,avg} \\cdot V_{\\text{milk}} $$\nSubstituting the expression for $C_{milk,avg}$:\n$$ Dose_{infant} = \\left( R \\cdot \\frac{F \\cdot D}{CL \\cdot \\tau} \\right) \\cdot V_{\\text{milk}} $$\n\nFinally, we calculate the hazard quotient, $HQ$, which is defined as the ratio of the infant's daily dose to the pediatric minimum therapeutic threshold, $T_{\\text{ped}}$.\n$$ HQ = \\frac{Dose_{infant}}{T_{\\text{ped}}} $$\nSubstituting the full expression for $Dose_{infant}$:\n$$ HQ = \\frac{1}{T_{\\text{ped}}} \\cdot \\left( R \\cdot \\frac{F \\cdot D}{CL \\cdot \\tau} \\right) \\cdot V_{\\text{milk}} $$\n\nWe now substitute the given numerical values into this final expression.\n$F = 0.70$\n$D = 300$ mg\n$\\tau = 12$ h\n$CL = 15$ L/h\n$R = 0.90$\n$V_{\\text{milk}} = 0.15$ L$\\cdot$kg$^{-1}\\cdot$day$^{-1}$\n$T_{\\text{ped}} = 5$ mg$\\cdot$kg$^{-1}\\cdot$day$^{-1}$\n\nFirst, let's calculate the value of the term in parentheses, which represents $C_{milk,avg}$:\n$$ C_{milk,avg} = 0.90 \\cdot \\frac{0.70 \\cdot 300 \\, \\text{mg}}{15 \\, \\text{L/h} \\cdot 12 \\, \\text{h}} = 0.90 \\cdot \\frac{210 \\, \\text{mg}}{180 \\, \\text{L}} = 0.90 \\cdot \\frac{7}{6} \\, \\frac{\\text{mg}}{\\text{L}} = 1.05 \\, \\frac{\\text{mg}}{\\text{L}} $$\nNext, calculate the infant dose:\n$$ Dose_{infant} = 1.05 \\, \\frac{\\text{mg}}{\\text{L}} \\cdot 0.15 \\, \\frac{\\text{L}}{\\text{kg} \\cdot \\text{day}} = 0.1575 \\, \\frac{\\text{mg}}{\\text{kg} \\cdot \\text{day}} $$\nFinally, compute the hazard quotient:\n$$ HQ = \\frac{0.1575 \\, \\text{mg} \\cdot \\text{kg}^{-1} \\cdot \\text{day}^{-1}}{5 \\, \\text{mg} \\cdot \\text{kg}^{-1} \\cdot \\text{day}^{-1}} = 0.0315 $$\nThe problem requires the final answer to be rounded to three significant figures. The value $0.0315$ has exactly three significant figures ($3$, $1$, and $5$). Thus, no further rounding is necessary.\n$$ HQ = 0.0315 $$",
            "answer": "$$\\boxed{0.0315}$$"
        }
    ]
}